Blood Pressure Treatment Targets in Adults with Hypertension: A Guideline Topline

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Adequate sleep tops the 4 elements most important to CV health after menopause, with blood pressure, glucose levels, and smoking status close behind.

FDA Label Update Positions Inclisiran as First-Line Monotherapy for Hypercholesterolemia

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Inclisiran can now be used without a background statin, as an adjunct to changes in diet and physical activity for reduction of LDL-C in hypercholesterolemia.

New Guidelines Recommend Preconception Screening in Diabetes, Universal Testing for Primary Aldosteronism

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

FDA Approves Finerenone for Heart Failure With LVEF ≥40% Following Positive Phase 3 Data

ENDO 2025: The publications reflect growing consensus that integration of endocrine screening into standard clinical workflows is essential for early risk detection and long-term disease prevention.

Only 1 in 5 Women Meet Heart Health Targets at Midlife, and These 4 Factors Matter Most

FDA approval based on FINEARTS-HF trial showing 16% risk reduction in CV death and HF events.

Related Content

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Adequate sleep tops the 4 elements most important to CV health after menopause, with blood pressure, glucose levels, and smoking status close behind.

FDA Label Update Positions Inclisiran as First-Line Monotherapy for Hypercholesterolemia

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Inclisiran can now be used without a background statin, as an adjunct to changes in diet and physical activity for reduction of LDL-C in hypercholesterolemia.

New Guidelines Recommend Preconception Screening in Diabetes, Universal Testing for Primary Aldosteronism

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

FDA Approves Finerenone for Heart Failure With LVEF ≥40% Following Positive Phase 3 Data

ENDO 2025: The publications reflect growing consensus that integration of endocrine screening into standard clinical workflows is essential for early risk detection and long-term disease prevention.